CXCL8 and pancreatic neoplasm: Sorting the data in Table 1 based on AdCre injection with or without IL-8 co-administration revealed pancreatic tumor in 7/9 OCM subjects with IL-8 versus 3/5 subjects without IL-8 (P>0.48, chi-square), with early euthanasia at 15±4 and 24±9 days, respectively (P>0.2, unpaired two-tailed Student's t-test).